Outcomes in Critical COVID 19 Infection Affected by Pre-Existing Diabetes Mellitus
Abstract
To determine the effect of pre-existing diabetes mellitus on disease course in COVID-19 infection.
This retrospective observational study was done from Jan 2021 to August 2021. We included patients with COVID-19 infection having a positive PCR for SARS-CoV-2. Exclusion criteria included missing data or a negative PCR for SARS-CoV-2. Patients were selected using consecutive sampling. Length of stay and death within hospital were compared amongst diabetic and non- diabetic patients.
The 279 patients were aged 52.53± 11.31 years. Of these, 216 (77.42%) were males and 92 (32.97%) had diabetes. They remained admitted for 10.18± 3.13 days. The period of hospitalization was similar in diabetics and non- diabetics (10.70± 3.51 days vs 9.92± 2.91 days; p=0.052). Amongst the diabetics, 43(46.74%) died in hospital in comparison with 53 (39.55%) non- diabetics (p=0.002). The risk of in-hospital death in diabetics was 1.673 (95% CI 1.207 - 2.319).
Diabetes mellitus is linked with greater risk of death, longer duration of hospital stay and higher need for critical care and novel therapy in COVID-19 infection.
How to Cite This Article
Saeed B, Arshad AR, Rehman HMY. Outcomes in Critical COVID 19 Infection Affected by Pre-Existing Diabetes Mellitus. J Pak Soc Intern Med. 2023;4(1):20–23. doi:10.70302/jpsim.v4i1.2305
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-33.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-69.
- Li G, Chen Z, Lv Z, Li H, Chang D, Lu J. Diabetes mellitus and COVID-19: associations and possible mechanisms. Int J Endocrinol. 2021; PMC 7394378.
- Corrao S, Pinelli K, Vacca M, Raspanti M, Argano C. Type 2 diabetes mellitus and COVID-19: a narrative review. Front Endocrinol. 2021; doi: 10.3389/fendo.2021.609470. doi:10.3389/fendo.2021.609470
- Hui Y, Li Y, Tong X, Wang Z, Mao X, Huang L, et al. The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan. PLoS One. 2020; 15(12):e0243602.
- National Institutes of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Maryland: Available from: [https://www.covid19treatmentguidelines.nih.gov/]
- Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94(1):91-95.
- Chen Y, Gong X, Wang L, Guo J. Effects of Hypertension, Diabetes and Coronary Heart Disease on COVID-19 Diseases Severity: A Systematic Review and Meta-Analysis. medRxiv 2020;doi: https://doi.org/10.1101/2020.03.25.20043133. doi:10.1101/2020.03.25.20043133
- Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020; 31(6):1068-1077.e3.
- Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020;14(4):813-821.
- Azar WS, Njeim R, Fares AH, Azar NS, Azar ST, El Sayed M, et al. COVID-19 and diabetes mellitus: how one pandemic worsens the other. Rev Endocr Metab Disord. 2020;21(4):451-463.
- Zhang W, Li C, Xu Y, He B, Hu M, Cao G, et al. Hyperglycemia and correlated high levels of inflammation have a positive relationship with the severity of coronavirus disease 2019. Mediators Inflamm. 2021; Article ID 8812304.
- Shauly-Aharonov M, Shafrir A, Paltiel O, Calderon-Margalit R, Safadi R, Bicher R, et al. Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study. PLoS One. 2021; 16(7):e0254847.
- Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020; doi: 10.1016/j.jcv.2020.104354. doi:10.1016/j.jcv.2020.104354
- Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584(7821):430-6.
- Saeed B, Arshad AR. Outcome of severe/critical Covid-19 infection in patients with
- and without diabetes mellitus. Khyber Med Univ J. 2021;13(Suppl 1):S9.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.